Muc4/sialomucin complex in the mammary gland and breast cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 6, Issue 3, 2001, Pages 323-337

  Carraway, Kermit L ^a   Price Schiavi, Shari A ^a   Komatsu, Masanobu ^a   Jepson, Scott ^a   Perez, Aymee ^a   Carothers Carraway, Coralie A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Antiadhesion; Breast carcinoma; Epithelia; ErbB2; Mucin; Regulation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LIGAND; MONOCLONAL ANTIBODY; MUCIN; MUCIN 4; POLYCLONAL ANTIBODY; SIALOMUCIN; TRANSFORMING GROWTH FACTOR BETA; MEMBRANE ANTIGEN; TUMOR MARKER;

APOPTOSIS; BASEMENT MEMBRANE; BREAST CANCER; BREAST CARCINOMA; BREAST DEVELOPMENT; BREAST MILK; CANCER CELL; CANCER GROWTH; CELL SURFACE; EPITHELIUM CELL; GENE SEQUENCE; HUMAN; MAMMARY GLAND FUNCTION; METASTASIS; MOLECULAR CLONING; NONHUMAN; PREGNANCY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; ANIMAL; BREAST; BREAST TUMOR; CELL ADHESION; DISEASE COURSE; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIGENS, SURFACE; BREAST; BREAST NEOPLASMS; CELL ADHESION; DISEASE PROGRESSION; FEMALE; HUMANS; MUCINS; RECEPTOR, ERBB-2; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

EID: 0035405011     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011327708973     Document Type: Review

References (91)

1. G. J. Strous and J. Dekker (1992). Mucin-type glycoproteins. Crit. Rev. Biochem. Mol. Biol. 27:57-92.
2. S. J. Gendler and A. P. Spicer (1995). Epithelial mucin genes. Annu. Rev. Physiol. 57:607-634.
3. K. L. Carraway and N. Fregien (1995). Mucin structure and function: Insights from molecular biology. Trends Glycosci. Glycotechnol. 7:31-44.
4. N. Jentoft (1990). Why are proteins O-glycosylated? Trends Biochem. Sci. 15:291-294.
5. J. Perez-Vilar and R. L. Hill (1999). The structure and assembly of secreted mucins. J. Biol. Chem. 274:31751-31754.
6. L. A. Bobek, H. Tsai, A. R. Biesbrock, and M. J. Levine (1993). Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J. Biol. Chem. 268:20563-20569.
7. R. R. McNeer, S. Price-Schiavi, M. Komatsu, N. Fregien, C. A. C. Carraway, and K. L. Carraway (1997). Sialomucin complex in tumors and tissues. Front. Biosci. 2:449-459.
8. R. R. McNeer, D. Huang, N. L. Fregien, and K. L. Carraway (1998). Sialomucin complex in the rat respiratory tract: A model for its role in epithelial protection. Biochem. J. 330:737-744.
9. J. F. Codington, B. H. Sanford, and R. W. Jeanloz (1973). Cell-surface glycoproteins of two sublines of the TA3 tumor. J. Natl. Cancer Inst. 51:585-591.
10. J. F. Codington, B. H. Sanford, and R. W. Jeanloz (1972). Glycoprotein coat of the TA3 cell. Isolation and partial characterization of a sialic acid containing glycoprotein fraction. Biochemistry 11: 559-2564.
11. J. F. Codington and S. Haavik (1992). Epiglycanin - a carcinoma-specific mucin-type glycoprotein of the mouse TA3 tumour. Glycobiol. 2:173-180.
12. A. G. Cooper, J. F. Codington, and M. C. Brown (1974). In vivo release of glycoprotein I from the Ha subline of TA3 murine tumor into ascites fluid and serum. Proc. Natl. Acad. Sci. USA 71: 224-1228.
13. J. F. Codington, G. Klein, A. G. Cooper, N. Lee, M. C. Brown, and R. W. Jeanloz (1978). Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: Studies on segregating TA3-HA hybrids. J. Natl. Cancer Inst. 60:811-818.
14. S. C. Miller, J. F. Codington, and G. Klein (1982). Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell. J. Natl. Cancer Inst. 68:981-988.
15. J. F. Codington (1978). Masking of cell-surface antigens by ectoglycoproteins. In E. F. Walborg (ed.), Glycoproteins and Glycolipids in Disease Processes, Washington, American Chemical Society, pp. 277-294.
16. H. S. Slayter and J. F. Codington (1973). Size and configuration of glycoprotein fragments cleaved from tumor cells by proteolysis. J. Biol. Chem. 248:3405-3410.
17. D. H. van den Eijnden, N. A. Evans, J. F. Codington, V. Reinhold, C. Silber, and R. W. Jeanloz (1979). Chemical structure of epiglycanin, the major glycoprotein of the TA3-Ha ascites cell. The carbohydrate chains. J. Biol. Chem. 254:12153-12159.
18. S. Haavik, M. Nilsen, T. Thingstad, H. Barsett, D. V. Renouf, E. F. Hounsell, and J. F. Codington (1999). Specificity studies of an antibody developed against a mucin-type glycoprotein. Glycoconj. J. 16:229-236.
19. J. F. Codington, V. P. Bhavanandan, K. J. Bloch, N. Nikrui, J. V. Ellard, P. S. Wang, and R. W. Jeanloz (1984). Antibody to epiglycanin and radioimmunoassay to detect epiglycanin-related glycoproteins in body fluids of cancer patients. J. Natl. Cancer Inst. 73: 029-1038.
20. A. P. Sherblom, R. L. Buck, and K. L. Carraway (1980). Purification of the major sialoglycoproteins of 13762 MAT-B1 and MAT-C1 rat ascites mammary adenocarcinoma cells by density gradient centrifugation in cesium chloride and guanidine hydrochloride. J. Biol. Chem. 255: 83-790.
21. A. P. Sherblom and K. L. Carraway (1980). A complex of two cell surface glycoproteins from ascites mammary adenocarcinoma cells. J. Biol. Chem. 255:12051-12059.
22. N. Moniaux, S. Nollet, N. Porchet, P. Degand, A. Laine, and J.-P. Aubert (1999). Complete sequence of the human mucin MUC4: A putative cell membrane-associated mucin. Biochem. J. 338:325-333.
23. L. D. Snow, D. G. Colton, and K. L. Carraway (1977). Purification and properties of the major sialoglycoprotein of the milk fat globule membrane. Arch. Biochem. Biophys. 179:690-696.
24. D. Kobylka and K. L. Carraway (1972). Proteins and glycoproteins of the milk fat globule membrane. Biochim. Biophys. Acta 288: 82-295.
25. J. A. Peterson, D. T. Zava, A. K. Duwe, E. W. Blank, H. Battifora, and R. L. Ceriani (1990). Biochemical and histological characterization of antigens preferentially expressed on the surface and cytoplasm of breast carcinoma cells identified by monoclonal antibodies against the human milk fat globule. Hybridoma 9:221-235.
26. R. L. Ceriani and E. H. Rosenbaum (1990). Breast epithelial antigens in the circulation of breast cancer patients. Immunol. Series 53: 23-241.
27. D. F. Hayes, V. R. Zurawski Jr., and D. W. Kufe (1986). Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. J. Clin. Oncol. 4:1542-1550.
28. K. O. Lloyd, J. Burchell, V. Kudryashov, B. W. T. Yin, and J. Taylor-Papadimitriou (1996). Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem. 271:33325-33334.
29. J. Burchell (2001). O-linked glycosylation in the mammary gland: changes that occur during malignancy. J Mammary Gland Biol. Neoplasia 6:355-364.
30. S. J. Gendler, C. A. Lancaster, J. Taylor-Papadimitriou, T. Duhig, N. Peat, J. Burchell, L. Pemberton, E. N. Lalani, and D. Wilson (1990). Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem. 265:15286-15293.
31. M. J. Ligtenberg, H. L. Vos, A. M. Gennissen, and J. Hilkens (1990). Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J. Biol. Chem. 265:5573-5578.
32. B. Griffiths, A. Gordon, J. Burchell, M. E. Bramwell, A. Griffiths, M. Price, J. Taylor-Papadimitriou, D. Zanin, and D. M. Swallow (1988). The breast tumour-associated epithelial mucins and the peanut lectin binding urinary mucins are coded by a single highly polymorphic gene locus "PUM". Disease Markers 6:185-194.
33. S. J. Gendler (2001) MUC1, the renaissance molecule. J. Mammary Gland Biol. Neoplasia 6:339-354.
34. M. Shimizu, K. Yamauchi, Y. Miyauchi, T. Sakurai, K. Tokugawa, and R. A. McIlhinney (1986). High-Mr glycoprotein profiles in human milk serum and fat-globule membrane. Biochem. J. 233:725-730.
35. S. Patton, S. J. Gendler, and A. P. Spicer (1995). The epithelial mucin, MUC1, of milk, mammary gland and other tissues. Biochim. Biophys. Acta 1241:407-423.
36. E. A. Rossi, R. McNeer, S. A. Price-Schiavi, M. Komatsu, J. M. H. van den Brande, J. F. Thompson, C. A. C. Carraway, N. L. Fregien, and K. L. Carraway (1996). Sialomucin complex, a heterodimeric glycoprotein complex: Expression as a soluble, secretable form in lactating mammary gland and colon. J. Biol. Chem. 271:33476-33485.
37. S. R. Hull, R. A. Laine, T. Kaizu, I. Rodriguez, and K. L. Carraway (1984). Structures of the O-linked oligosaccharides of the major cell surface sialoglycoprotein of MAT-B1 and MAT-C1 ascites sublines of the 13762 rat mammary adenocarcinoma. J. Biol. Chem. 259: 866-4877.
38. S. R. Hull, A. Bright, K. L. Carraway, M. Abe, D. F. Hayes, and D. W. Kufe (1989). Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun. 1:261-267.
39. S. R. Hull, Z. Sheng, O. Vanderpuye, C. David, and K. L. Carraway (1990). Isolation and partial characterization of ascites sialoglycoprotein-2 (ASGP-2) of the cell surface sialomucin complex of 13762 rat mammary adenocarcinoma cells. Biochem. J. 265:121-129.
40. P. Li, S. A. Price-Schiavi, P. S. Rudland, and K. L. Carraway (2001). Sialomucin Complex (rat Muc4) transmembrane subunit binds the differentiation marker peanut lectin in the normal rat mammary gland. J. Cell. Physiol. 186:397-405.
41. O. A. Vanderpuye, C. A. C. Carraway, and K. L. Carraway (1988). Microfilament association of ASGP-2, the concanavalin A-binding glycoprotein of the cell surface sialomucin complex of 13762 rat mammary ascites tumor cells. Exp. Cell Res. 178:211-223.
42. J. Spielman, S. R. Hull, Z. Sheng, R. Kanterman, A. Bright, and K. L. Carraway (1988). Biosynthesis of a tumor cell surface sialomucin: Maturation and effects of monensin. J. Biol. Chem. 263: 621-9629.
43. Z. Sheng, S. R. Hull, and K. L. Carraway (1990). Biosynthesis of the cell surface sialomucin complex of ascites 13762 rat mammary adenocarcinoma cells from a high Mr precursor. J. Biol. Chem. 265: 505-8510.
44. Z. Sheng, K. Wu, K. L. Carraway, and N. Fregien (1992). Molecular cloning of the transmembrane component of the 13762 mammary adenocarcinoma sialomucin complex: A new member of the epidermal growth factor superfamily. J. Biol. Chem. 267:16341-16346.
45. K. Wu, N. Fregien, and K. L. Carraway (1994). Molecular cloning and sequencing of the mucin subunit of a heterodimeric, bifunctional cell surface glycoprotein complex of ascites rat mammary adenocarcinoma cells. J. Biol. Chem. 269:11950-11955.
46. N. Porchet, V. C. Nguyen, J. Dufosse, J.-P. Audie, V. Guyonnet-Duperat, M. S. Gross, C. Denis, P. Degand, A. Bernheim, and J.-P. Aubert (1991). Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem. Biophys. Res. Commun. 175:414-422.
47. S. Nollet, N. Moniaux, J. Maury, D. Petitprez, P. Degand, A. Laine, N. Porchet, and J.-P. Aubert (1998). Human mucin gene MUC4: Organization of its 5′-region and polymorphism of its central tandem repeat array. Biochem. J. 332:739-748.
48. R. R. McNeer, C. A. C. Carraway, N. L. Fregien, and K. L. Carraway (1998). Characterization of the expression and steroid hormone control of sialomucin complex in the rat uterus: Implications for uterine receptivity. J. Cell. Physiol. 176:110-119.
49. S. A. Price-Schiavi, D. Meller, X. Jing, J. Merritt, M. E. Carvajal, S. C. G. Tseng, and K. L. Carraway (1998). Sialomucin complex at the rat ocular surface: A new model for ocular surface protection. Biochem. J. 335:457-463.
50. N. Idris and K. L. Carraway (1999). Sialomucin complex (Muc4) expression in the rat female reproductive tract. Biol. Reprod. 61:1431-1438.
51. I. K. Gipson, S. B. Ho, S. J. Spurr-Michaud, A. S. Tisdale, Q. Zhan, E. Torlakovic, J. Pudney, D. J. Anderson, N. W. Toribara, and J. A. Hill (1997). Mucin genes expressed by human female reproductive tract epithelia. Biol. Reprod. 56:999-1011.
52. I. K. Gipson (2000). In situ hybridization techniques for localizing mucin mRNA. Meth. Mol. Biol. 125:323-336.
53. M. E. Arango, P. Li, M. Komatsu, C. A. C. Carraway, and K. L. Carraway. Production of mucins in the rat lacrimal gland: A new source of sialomucin complex (Muc4) for the ocular tear film. Submitted for publication.
54. P. Li, M. E. Arango, R. E. Perez, C. A. Reis, E. L. Bonfante, D. Weed, and K. L. Carraway (2001). Expression and localization of immunoreactive-sialomucin complex (Muc4) in salivary glands. Tissue Cell 33:111-118.
55. N. A. McNamara, R. A. Sack, and S. M. Fleiszig (2000). Mucin-bacterial binding assays. Meth. Mol. Biol. 125:429-437.
56. D. S. Newburg (1996). Oligosaccharides and glycoconjugates in human milk: Their role in host defense. J. Mammary Gland Biol. Neoplasia 1: 71-283.
57. S. A. Price-Schiavi, C. A. C. Carraway, N. Fregien, and K. L. Carraway (1998). Post-transcriptional regulation of a milk membrane protein, the sialomucin complex (ascites sialoglycoprotein (ASGP)-1/ASGP-2, rat Muc4) by TGFβ. J. Biol. Chem. 273:35228-35237.
58. C. Balague, J.-P. Audie, N. Porchet, and F. X. Real (1995). In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. Gastroenterol. 109: 53-964.
59. C. Balague, G. Gambus, C. Carrato, N. Porchet, J.-P. Aubert, Y. S. Kim, and F. X. Real (1994). Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterol. 106:1054-1061.
60. R. L. Giuntoli II, G. C. Rodriguez, R. S. Whitaker, R. Dodge, and J. A. Voynow (1998). Mucin gene expression in ovarian cancers. Cancer Res. 58:5546-5550.
61. E. Seregni, C. Botti, C. Lombardo, A. Cantoni, A. Bogni, I. Cataldo, and E. Bombardieri (1996). Pattern of mucin gene expression in normal and neoplastic lung tissues. Anticancer Res. 16:2209-2213.
62. M. Komatsu, L. Yee, and K. L. Carraway (1999). Overexpression of sialomucin complex, a rat homolog of MUC4, inhibits tumor killing by lymphokine-activated killer cells. Cancer Res. 59:2229-2236.
63. V. Piller, F. Piller, F. G. Klier, and M. Fukuda (1989). O-glycosylation of leukosialin in K562 cells. Evidence for initiation and elongation in early Golgi compartments. Eur. J. Biochem. 183: 23-135.
64. S. A. Tooze, J. Tooze, and G. Warren (1988). Site of addition of N-acetyl-galactosamine to the E1 glycoprotein of mouse hepatitis virus-A59. J. Cell Biol. 106:1475-1487.
65. N. Moniaux, F. Escande, S. K. Batra, N. Porchet, A. Laine, and J.-P. Aubert (2000). Alternative splicing generates a family of putative secreted and membrane-associated MUC4 mucins. Eur. J. Biochem. 267:4536-4544.
66. M. Komatsu (1998). Multifunctional activities and contribution to metastasis of sialomucin complex. Ph.D. Thesis, University of Miami.
67. J. Wesseling, S. W. van der Valk, H. L. Vos, A. Sonnenberg, and J. Hilkens (1995). Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J. Cell Biol. 129:255-265.
68. J. Wesseling, S. W. van der Valk, and J. Hilkens (1996). A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol. Biol. Cell 7: 65-757.
69. E. van de Wiel-van Kemenade, M. J. Ligtenberg, A. J. de Boer, F. Buijs, H. L. Vos, C. J. Melief, J. Hilkens, and C. G. Figdor (1993). Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J. Immunol. 151:767-776.
70. M. Komatsu, C. A. C. Carraway, N. L. Fregien, and K. L. Carraway (1997). Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex. J. Biol. Chem. 272: 3245-33254.
71. K. L. Carraway, J. W. Huggins, A. P. Sherblom, R. W. Chesnut, R. L. Buck, S. P. Howard, C. L. Ownby, and C. A. C. Carraway (1978). Membrane glycoproteins of rat mammary gland and its metastasizing and nonmetastasizing tumors. ACS Symposium Series No. 80, Glycoproteins and Glycolipids in Disease Processes, pp. 432-445.
72. M. Komatsu, S. Jepson, M. E. Arango, C. A. C. Carraway, and K. L. Carraway (2001). Muc4/Sialomucin Complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor. Oncogene 20:461-470.
73. M. Komatsu, L. Tatum, N. H. Altman, C. A. C. Carraway, and K. L. Carraway (2000). Potentiation of metastasis by cell surface sialomucin complex (rat Muc4), a multifunctional anti-adhesive glycoprotein. Int. J. Cancer 87:480-486.
74. S. M. Frisch and E. Ruoslahti (1997). Integrins and anoikis. Curr. Opin. Cell Biol. 9:701-706.
75. K. L. Carraway, N. Fregien, C. A. C. Carraway, and K. L. Carraway III (1992). Tumor sialomucin complexes as tumor antigens and modulators of cellular interactions and proliferation. J. Cell Sci. 103: 99-307.
76. C. A. C. Carraway, M. E. Carvajal, and K. L. Carraway (1999). Association of the Ras/MAP kinase signal transduction pathway with microfilaments. Evidence for a p185neu-containing cell surface signal transduction particle. J. Biol. Chem. 274:25659-25667.
77. S.-H. Juang, J. Huang, Y. Li, P. J. I. Salas, N. Fregien, C. A. C. Carraway, and K. L. Carraway (1994). Molecular cloning and sequencing of a 58 kda membrane- and microfilament-associated protein from ascites tumor cell microvilli with sequence similarities to retroviral gag proteins. J. Biol. Chem. 269:15067-15075.
78. K. L. Carraway III, E. A. Rossi, M. Komatsu, S. A. Price-Schiavi, D. Huang, P. M. Guy, M. E. Carvajal, N. Fregien, C. A. C. Carraway, and K. L. Carraway (1999). An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J. Biol. Chem. 274:5263-5266.
79. K. L. Carraway III and L. C. Cantley (1994). A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling. Cell 78:5-8.
80. X. Zhu, S. A. Price-Schiavi, and K. L. Carraway (2000). Extracellular regulated kinase (erk)-dependent regulation of sialomucin complex/MUC4, the intramembrane ErbB2 ligand, in mammary epithelial cells. Oncogene 19:4354-4361.
81. T. L. Wood and D. Yee (2000). IGFs and IGFBPs in the normal mammary gland and in breast cancer. J. Mammary Gland Biol. Neoplasia 5: -5.
82. D. J. Dunnington, C. M. Hughes, P. Monaghan, and P. S. Rudland (1983). Phenotypic instability of rat mammary tumor epithelial cells. J. Natl. Cancer Inst. 71:1227-1240.
83. P. S. Rudland (1992). Use of peanut lectin and rat mammary stem cell lines to identify a cellular differentiation pathway for the alveolar cell in the rat mammary gland. J. Cell. Physiol. 153:157-168.
84. A. Choudhury, N. Moniaux, J. P. Winpenny, M. A. Hollingsworth, J.-P. Aubert, and S. K. Barra (2000). Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J. Biochem. 128:233-243.
85. S. A. Price-Schiavi, A. Perez, R. Barco, and K. L. Carraway, (2000). Cloning and characterization of the 5′ flanking region of the Sialomucin complex/Rat Muc4 gene: Promoter activity in cultured cells. Biochem. J. 349:641-649.
86. S. A. Price-Schiavi, X. Zhu, R. Aquinin, and K. L. Carraway (2000). Sialomucin complex (rat Muc4) is regulated by transforming growth factor in mammary gland by a novel post-translational mechanism. J. Biol. Chem. 275:17800-17807.
87. N. Idris and K. L. Carraway (2000). Regulation of Sialomucin complex/Muc4 expression in rat uterine luminal epithelial cells by transforming growth factor-β: Implications for blastocyst implantation. J. Cell. Physiol. 185:310-316.
88. G. L. Nicolson (1976). Transmembrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. Biochim. Biophys. Acta 458:1-72.
89. K. L. Schmeichel, V. M. Weaver, and M. J. Bissell (1998). Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype. J. Mammary Gland Biol. Neoplasia 3:201-213.
90. K. M. Koli and C. L. Arteaga (1996). Complex role of tumor cell transforming growth factor (TGF)-beta s on breast carcinoma progression. J. Mammary Gland Biol. Neoplasia 1:373-380.
91. J. J. Oh, D. R. Grosshans, S. G. Wong, and D. J. Slamon (1999). Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells. Nucleic Acids Res. 27:4008-4017.